View Heights Conv Hosp
VIEW HEIGHTS CONV HOSP in LOS ANGELES, CA — inspection on February 14, 2025.
Found 1 citation. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
During a review of Resident 3's Minimum Data Set (MDS, a resident assessment tool), dated 12/15/2024, the MDS indicated Resident 3 did not have cognitive impairments (problems with thinking, learning, or memory).
The MDS indicated Resident 3 did not exhibit physical or verbal behaviors (e.g., physical aggression towards others and/or verbal aggression/threats towards others).
The MDS indicated Resident 3 did not reject care.
The MDS indicated Resident 3 could eat independently and was independent with mobility while in and out of bed.
During a review of Resident 3's physician orders, dated 3/21/2024, the order indicated Resident 3 was to receive Cymbalta 30 milligrams (mg, a unit of dose measurement), every morning, for depression manifested by self-isolative behavior.
During an interview, on 2/13/2025 at 11:23 a.m., with the Director of Nursing (DON), DON stated Resident 3 did not have a care plan to address or treat the self-isolative behavior the Cymbalta was ordered for on 3/21/2024.
The DON stated there were non-pharmacologic interventions staff could attempt to address self-isolative behavior, prior to initiating psychotropic medications.
The DON stated non-pharmacological interventions included counseling, group activities, and outdoor fitness programs.
The DON stated non-pharmacological interventions should always be attempted before psychotropic medications, and stated these interventions would be documented in a care plan.
The DON stated Resident 3 should have a care plan for self-isolative behavior to monitor if non-pharmacological interventions were effective in addressing the behavior to allow for a decrease or discontinuation of the Cymbalta.
056417
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 056417 B.
Wing 02/14/2025
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
View Heights Conv Hosp 12619 S.
Avalon Blvd Los Angeles, CA 90061